Bicara Therapeutics Inc. Common Stock (BCAX) Analyst Forecast

$15.66

$1.07 (7.33%)
Last update: 04:00 PM EST
Day's range
$13.7
Day's range
$15.69

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
10/08/2024 Morgan Stanley Judah Frommer $35.00 $24.45   43.15%

Bicara Therapeutics Inc. Common Stock FAQ's

Bicara Therapeutics Inc. Common Stock has been rated by research analysts at Stifel Nicolaus, Morgan Stanley in the past 90 days.